AVBP
NASDAQ · Biotechnology
Arrivent Biopharma Inc
$13.49
+0.47 (+3.61%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+89.8% upside
Low Target
$15.99
Average Target
$25.60
High Target
$32.44
Current Price
$13.49
Current
$13.49
$13.49
Target
$25.60
$25.60
$15.99
$25.60 avg
$32.44
Scenario Analysis
Bear Case
$15.99
18.5%
Low target
Base Case
$25.60
+89.8%
Avg target
Bull Case
$32.44
+140.5%
High target
Risk/Reward
7.6x
Highly favorable
Price in Context
52-Week High
$35.83
-62.3% from high
52-Week Low
$11.36
+18.8% from low
Target vs 52W High
$25.60
-28.6% vs high
Next Earnings Report
Nov 18, 2026
10d
until earnings
EPS Est: $-1.08
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |